Untitled

Long-term protection against atherosclerosis in a mouse model of familial hypercholesterolemia.
Long-term protection against atherosclerosis in a mouse model of familial hypercholesterolemia. Gene therapy 2004, 11(20):1540-1548. 140. Jacobs F, Van Craeyveld E, Feng Y, Snoeys J, De Geest B: Adenoviral low density lipoprotein receptor attenuates progression of atherosclerosis and decreases tissue cholesterol levels in a murine model of familial hypercholesterolemia. Atherosclerosis 2008, 201(2):289-297. 141. Oka K, Pastore L, Kim IH, Merched A, Nomura S, Lee HJ, MerchedSauvage M, Arden-Riley C, Lee B, Finegold M, Beaudet A, Chan L: Longterm stable correction of low-density lipoprotein receptor-deficient mice with a helper-dependent adenoviral vector expressing the very lowdensity lipoprotein receptor. Circulation 2001, 103(9):1274-1281. 142. Isner JM, Asahara T: Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. The Journal of clinical investigation 1999, 103(9):1231-1236. PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/27196668 143. Nathwani AC, McIntosh J, Davidoff AM: An update on gene therapy for hemophilia. Curr Hematol Rep 2005, 4(4):LY294002 cost 287-293. 144. Manno CS, Pierce GF, Arruda VR, Glader B, Ragni M, Rasko JJ, Ozelo MC, Hoots K, Blatt P, Konkle B, Dake M, Kaye R, Razavi M, Zajko A, Zehnder J, Rustagi PK, Nakai H, Chew A, Leonard D, Wright JF, Lessard RR, Sommer JM, Tigges M, Sabatino D, Luk A, Jiang H, Mingozzi F, Couto L, Ertl HC, High KA, et al: Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response. Nature medicine 2006, 12(3):342-347. 145. Muzyczka N, Berns KI: Parvoviridae, The viruses and their replication. In Fields Virology. Volume 2.. 4 edition. Edited by: Fields B, Knipe D, Howley P. Philadelphia: Lippincott-William and Wilkins; 1999:2327-2379. 146. Davidoff AM, Gray JT, Ng CY, Zhang Y, Zhou J, Spence Y, Bakar Y, Nathwani AC: Comparison of the ability of adeno-associated viral vectors pseudotyped with serotype 2, 5, and 8 capsid proteins to mediate PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/26437915 efficient transduction of the liver in murine and nonhuman primate models. Mol Ther 2005, 11(6):875-888. 147. Davidoff AM, Ng CY, Zhou J, Spence Y, Nathwani AC: Sex significantly influences transduction of murine liver by recombinant adenoassociated viral vectors through an androgen-dependent pathway. Blood 2003, 102(2):480-488. 148. Duan D, Yue Y, Yan Z, Yang J, Engelhardt JF: Endosomal processing limits gene transfer to polarized airway epithelia by adeno-associated virus. The Journal of clinical investigation 2000, 105(11):1573-1587.149. Nathwani AC, Cochrane M, McIntosh J, Ng CY, Zhou J, Gray JT, Davidoff AM: Enhancing transduction of the liver by adeno-associated viral vectors. Gene therapy 2009, 16(1):60-69. 150. Fisher KJ, Gao GP, Weitzman MD, DeMatteo R, Burda JF, Wilson JM: Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis. Journal of virology 1996, 70(1):520-532. 151. Wang Z, Ma HI, Li J, Sun L, Zhang J, Xiao X: Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo. Gene therapy 2003, 10(26):2105-2111. 152. Nathwani AC, Gray JT, Ng CY, Zhou J, Spence Y, Waddington SN, Tuddenham EG, Kemball-Cook G, McIntosh J, Boon-Spijker M, Mertens K, Davidoff AM: Self-complementary adeno-associated virus vectors containing a novel liver-specific human factor IX expression cassette enable highly efficient transduction of murine and nonhuman primate liver. Blood 2006, 107(7):2653-2661. 153. Chen SJ, Rader DJ, Tazelaar J, Kaw.

Leave a Reply